These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33445035)

  • 1. Translating the success of prophylaxis in haemophilia to von Willebrand disease.
    Miesbach W; Berntorp E
    Thromb Res; 2021 Mar; 199():67-74. PubMed ID: 33445035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis in von Willebrand disease.
    Berntorp E
    Haemophilia; 2008 Nov; 14 Suppl 5():47-53. PubMed ID: 18786010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
    Holm E; Abshire TC; Bowen J; Álvarez MT; Bolton-Maggs P; Carcao M; Federici AB; Gill JC; Halimeh S; Kempton C; Key NS; Kouides P; Lail A; Landorph A; Leebeek F; Makris M; Mannucci P; Mauser-Bunschoten EP; Nugent D; Valentino LA; Winikoff R; Berntorp E
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):383-8. PubMed ID: 25688461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review.
    El Alayli A; Brignardello Petersen R; Husainat NM; Kalot MA; Aljabiri Y; Turkmani H; Britt A; El-Khechen H; Shahid S; Roller J; Motaghi S; Mansour R; Tosetto A; Abdul-Kadir R; Laffan M; Weyand A; Leebeek FWG; Arapshian A; Kouides P; James P; Connell NT; Flood VH; Mustafa RA
    Haemophilia; 2022 May; 28(3):373-387. PubMed ID: 35339117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
    Abshire TC; Federici AB; Alvárez MT; Bowen J; Carcao MD; Cox Gill J; Key NS; Kouides PA; Kurnik K; Lail AE; Leebeek FW; Makris M; Mannucci PM; Winikoff R; Berntorp E;
    Haemophilia; 2013 Jan; 19(1):76-81. PubMed ID: 22823000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience of prophylactic treatment in von Willebrand disease.
    Lethagen S
    Thromb Res; 2006; 118 Suppl 1():S9-11. PubMed ID: 16616322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand disease.
    Berntorp E
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S34-6. PubMed ID: 23109385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
    Berntorp E
    Semin Thromb Hemost; 2006 Sep; 32(6):621-5. PubMed ID: 16977572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.
    Peyvandi F; Castaman G; Gresele P; De Cristofaro R; Schinco P; Bertomoro A; Morfini M; Gamba G; Barillari G; Jiménez-Yuste V; Königs C; Iorio A; Federici AB
    Blood Transfus; 2019 Sep; 17(5):391-398. PubMed ID: 30747707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of prophylaxis in the management of von Willebrand disease: today and tomorrow.
    Abshire T
    Thromb Res; 2009 Nov; 124 Suppl 1():S15-9. PubMed ID: 19944256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prophylaxis in von Willebrand disease.
    Berntorp E; Petrini P
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S23-6. PubMed ID: 15849523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sixth Åland Island Conference on von Willebrand disease.
    Berntorp E; Trakymienė SS; Federici AB; Holstein K; Corrales-Medina FF; Pierce GF; Srivastava A; Prondzinski MVD; Johnsen JM; Zupan IP; Halimeh S; Nummi V; Roberts JC
    Haemophilia; 2022 Jul; 28 Suppl 5(Suppl 5):3-15. PubMed ID: 35861919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical diagnosis of von Willebrand disease.
    Federici AB
    Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of prophylaxis in bleeding disorders.
    Berntorp E; de Moerloose P; Ljung RC
    Haemophilia; 2010 Jul; 16 Suppl 5():189-93. PubMed ID: 20590880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome after Joint Bleeds in Von Willebrand Disease Compared to Haemophilia A: A Post Hoc Analysis.
    van Galen KPM; Timmer M; de Kleijn P; Leebeek FWG; Foppen W; Schutgens REG; Eikenboom J; Meijer K; Fijnvandraat K; Laros-van Gorkom BAP; Twisk JW; Mauser-Bunschoten EP; Fischer K;
    Thromb Haemost; 2018 Oct; 118(10):1690-1700. PubMed ID: 30273954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthopaedic surgery in patients with von Willebrand disease.
    Siboni SM; Biguzzi E; Solimeno LP; Pasta G; Mistretta C; Mannucci PM; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):133-40. PubMed ID: 23992395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.
    Holm E; Carlsson KS; Lövdahl S; Lail AE; Abshire TC; Berntorp E
    Haemophilia; 2018 Jul; 24(4):628-633. PubMed ID: 29626372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.